Literature DB >> 12447642

Uveitis in adult patients with poststreptococcal reactive arthritis: the first two cases reported associated with uveitis.

S Kobayashi1, N Tamura, M Ikeda, K Sakuraba, T Matsumoto, H Hashimoto.   

Abstract

We describe two adult patients with poststreptococcal reactive arthritis (PSRA), both of whom concomitantly developed uveitis. These are the first two cases reported. Because uveitis may result in permanent damage to visual acuity, this complication should be widely recognised in patients with PSRA and antibiotic prophylaxis should be considered for those with recurrent streptococcal infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447642     DOI: 10.1007/s100670200130

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  4 in total

1.  Granulomatous uveitis and reactive arthritis as manifestations of post-streptococcal syndrome.

Authors:  Kais Abderrahim; Ahmed Chebil; Yosra Falfoul; Mejda Bouladi; Leila El Matri
Journal:  Int Ophthalmol       Date:  2012-09-18       Impact factor: 2.031

2.  Post-streptococcal uveitis syndrome in a Caucasian population: a case series.

Authors:  David S Curragh; Clara E McAvoy; Madeleine Rooney; Eibhlin McLoone
Journal:  Eye (Lond)       Date:  2018-09-18       Impact factor: 3.775

Review 3.  Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet's disease, and iBCG-induced ReA.

Authors:  Yoshinori Taniguchi; Hirofumi Nishikawa; Takeshi Yoshida; Yoshio Terada; Kurisu Tada; Naoto Tamura; Shigeto Kobayashi
Journal:  Rheumatol Int       Date:  2021-05-01       Impact factor: 2.631

4.  Optic atrophy, necrotizing anterior scleritis and keratitis presenting in association with Streptococcal Toxic Shock Syndrome: a case report.

Authors:  Konstantinos I Papageorgiou; Alexander S Ioannidis; Petros S Andreou; Ajay J Sinha
Journal:  J Med Case Rep       Date:  2008-02-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.